Chapter One — 1.1 Background to the Study

Over the past decade, the relationship between health insurance enrollment and disease prevalence has become a subject of considerable debate among scholars and industry practitioners alike, particularly within the context of Selected Listed Manufacturing Firms in Nigeria where operating conditions differ markedly from more developed markets.

Within the context of Selected Listed Manufacturing Firms in Nigeria, this relationship carries particular significance. Organizations in this setting operate under a distinct combination of economic, regulatory, and market conditions that may amplify or dampen the effect of health insurance enrollment on disease prevalence, making a context-specific inquiry both timely and necessary.

1.2 Statement of the Problem

While health insurance enrollment is widely discussed in policy and industry circles, empirical evidence on its actual effect on disease prevalence within Selected Listed Manufacturing Firms in Nigeria remains sparse and, in places, contradictory. This lack of localized, rigorous evidence makes it difficult for decision-makers to know with confidence whether current approaches to health insurance enrollment are helping or hindering disease prevalence — a gap this study sets out to close.

1.3 Objectives of the Study

1. To examine the effect of Health Insurance Enrollment on disease prevalence in Selected Listed Manufacturing Firms in Nigeria.
2. To assess the extent to which health insurance enrollment influences disease prevalence within the study area.
3. To identify the challenges associated with health insurance enrollment in relation to disease prevalence.
4. To recommend strategies for optimizing health insurance enrollment in order to improve disease prevalence.

1.4 Research Questions

1. What is the effect of health insurance enrollment on disease prevalence in Selected Listed Manufacturing Firms in Nigeria?
2. To what extent does health insurance enrollment influence disease prevalence within the study area?
3. What challenges are associated with health insurance enrollment in relation to disease prevalence?
4. What strategies can be adopted to optimize health insurance enrollment in order to improve disease prevalence?

1.5 Significance of the Study

This study is significant to a range of stakeholders. For policymakers and regulators, the findings offer evidence to guide the design of frameworks that support healthier outcomes around disease prevalence. For managers and practitioners within Selected Listed Manufacturing Firms in Nigeria, the study provides practical insight into how health insurance enrollment can be better managed. Finally, it contributes to the academic literature on public health by extending existing knowledge into a specific empirical context, and offers a reference point for future researchers.

1.6 Scope of the Study

In terms of scope, this BSc study confines itself to Selected Listed Manufacturing Firms in Nigeria, focusing specifically on how health insurance enrollment relates to disease prevalence within that setting. Findings are interpreted within these boundaries rather than as universal claims applicable to every organization or market.